.
TELA financial statements
* Numbers in thousands
Year |
2019 | 2020 | TTM |
|---|---|---|---|
Capitalization * |
26 108 | 206 234 | 172 343 |
EV * |
11 049 | 162 667 | 162 667 |
Stock price $ |
14.78 | 14.3 | 11.95 |
Number of shares * |
1 766 | 14 422 | 14 422 |
EPS |
-12,70 | -2,00 | -2,00 |
Revenue * |
15 446 | 18 213 | 18 213 |
Net income * |
-22 425 | -28 794 | -28 794 |
Operating profit * |
-19 162 | -25 275 | -25 275 |
Total liabilities * |
36 960 | 37 432 | 37 432 |
Net debt * |
-5 774 | -43 567 | -43 567 |
Total assets * |
67 922 | 86 458 | 86 458 |
Equity * |
30 962 | 49 026 | 49 026 |
Cash and investments * |
54 587 | 74 394 | 74 394 |
Over the past 10 years, the maximum capitalization of TELA Bio, Inc. is 206 234, the minimum is 26 108. Maximum net income 0, Minimum net income -28 794. The maximum price of TELA shares is 14.78, the minimum price is 14.3.
.
TELA valuation
Year |
2019 | 2020 | TTM |
|---|---|---|---|
P/E |
-1,16 | -7,16 | -5,99 |
P/B |
0,84 | 4,21 | 3,52 |
P/S |
1,69 | 11,32 | 9,46 |
E/P |
-86% | -14% | -17% |
P/FCF |
-0,93 | -8,38 | -7,00 |
.
TELA profitability
Year |
2019 | 2020 | TTM |
|---|---|---|---|
ROE |
-72% | -59% | |
ROA |
-34% | -34% | |
ROIC |
-31% | -32% |